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Background: The evaluation of 24 h urinary oxalate excretion is the gold standard for diagnosing hyperoxaluria in
patients with recurrent urolithiasis. However, 24 h urine sample collection is cumbersome. Therefore we aim to
see if oxalate to creatinine ratio in random urine sample can be used as an alternative.
Materials and methods: A cross-sectional study was conducted at Section of Chemical Pathology, Department of
Pathology and Laboratory Medicine Aga Khan University Karachi from 1st February to December 31, 2019. A
total of 62 adult patients, 18–60 years of age with history of kidney stones presenting to the clinical laboratory
for 24 h urine oxalate estimation were invited to participate in the study after informed consent. Clinical details
were recorded on a structured questionnaire and patients were guided to submit 24 h urine and a random spot
urine sample. Urinary oxalate was measured on Micro lab 300 using a kit based on oxalate oxidase principle by
Trinity Biotech plc, Wicklow, Ireland following standard operating procedures. Urinary creatinine was measured
on ADVIA 1800 by Siemens, US using kinetic Jaffe reaction according to the manufacturer’s instructions. The
data was analyzed on SPSS.
Results: In a period of ten months, a total of 62 subjects were recruited; mean age was 32.4 ± 2.6 years. Males
were 49 (79.0%) and females were 13 (20.9%). Correlation was found to be (r = 0.289) by Spearman correlation
(p value < 0.005). Taking 24 h urinary oxalate as gold standard the sensitivity, specificity, positive predictive
value and negative predictive value of spot oxalate to creatinine ratio was 83.3%, 17.8%, 9.8% and 90.9%
respectively.
Conclusion: The random spot urine test cannot replace the 24 h urinary oxalate estimation in patients with
urolithiasis.

Oxalate is a metabolic end product of glyoxalate metabolism
excreted by the kidneys. It has a high affinity for calcium and form
calcium oxalate crystals, which has low solubility and are typically
deposited within the renal interstitium and tubular cells [1]. Hyper
oxaluria may present with recurrent kidney stones to end stage renal
disease and systemic oxalosis due to reduced urinary excretion when
glomerular filtration rate (GFR) falls below 30–40 mL/min per 1.73 m2
[2].
The evaluation of 24 h urinary oxalate excretion is considered gold
standard for diagnosing hyperoxaluria in patients with recurrent

urolithiasis [3]. However, 24 h urine sample collection is cumbersome
and often inaccurate due to factors such as the patient missing a urine
pass in the collection jar, the quantity of acid added preservative to the
container or the possibility of other liquid being added to the container
instead of urine to fulfill the volume requirement [4]. In addition, a
study by Parks et al. showed that principle stone risk factors and dietary
and environmental factors vary enough in 24 h urine samples making a
24 h urinary sample inadequate for correct diagnosis [5]. It is proposed
that a single specimen is not an ideal predictor of hyperoxaluria and the
final mean of two 24 h urine samples should be taken for diagnosis.

Abbreviations: HCL, Hydrochloric acid; CAP, College of American Pathologists; SPSS, Statistical Package for Social Sciences; PCNL, Percutaneous neph
rolithotomy; FTIR, Fourier Transform Infrared Spectroscopy.
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Considering these limitations 24 h urinary oxalate is usually not prac
tical to screen for hyperoxaluria. A second morning random urine
sample, for oxalate to creatinine ratio has been proposed as an alter
native [6,7].
Oxalate: creatinine ratio is considered a better index of oxalate
excretion as it avoids error from an inaccurately timed collection and
ease of calculation from a spot urine sample. This is an advantage
especially for children and severely ill patients. A correlation ‘r’ of 0.352
between 24 h urinary oxalate and spot urinary oxalate to creatinine ratio
was shown in the study by Hong et al. (p value 0.028). And found that
the two paired measurements did not show good agreement, based on
the estimated “limit of agreement” by the Bland and Altman test of
agreement [4]. The reason for the disagreement was believed to be due
to the time-to-time variations in the urinary oxalate concentrations that
vary according to the body hydration status, diurnal circadian rhythm
and period after food intake. Seema L et al. from India reported signif
icantly high oxalate: creatinine ratio in stone formers compared to
control group (p < 0.05) on spot urine samples and spot urinary samples
are recommended spot urinary samples as screening procedure for
hyperoxaluria [8].
The relationship of spot and 24 h urine oxalate has not been studied
in Pakistani population, where the frequency of undifferentiated
hyperoxaluria is seen in up to 43% of paediatric stone formers [9]. We
therefore studied the relationship between 24 h urinary oxalate excre
tion and spot urine oxalate to creatinine ratio to determine its clinical
utility against the use of 24 h urinary oxalate estimation which is the
standard practice.

normality of the data Shapiro Wilk test was applied. Descriptive statis
tics were given as mean, median and interquartile range (IQR). Fre
quency and percentages were calculated for gender distribution,
recurrent stone, and family history of urolithiasis respectively. Spear
man’s correlation was applied because data was non-parametric.
Concordance between 24 h and spot oxalate excretion was run and
Cohen’s kappa values were calculated. P-value ≤0.05 was taken as
statistically significant.
2. Results
In a period of ten months, a total of 62 subjects with urolithiasis were
recruited. Mean age was 32.4 ± 2.6 years. Males were 49 (79.0%) and
females were 13 (20.9%).
Majority of the subjects had ureteric stones (62.5%), followed by
renal and bladder stones in 28.2% & 6.3% respectively. Twenty subjects
had undergone surgery for stone removal (9 had extracorporeal shock
wave lithotripsy, 11 had PCNL). However, the stone analysis was
available in 7 cases (35%) only, which in all cases consist of calcium
oxalate crystals as the primary constituent. The stone analysis was done
by Fourier-transform infrared spectroscopy (FTIR).
The most common presenting complaint was flank pain (79.7%)
followed by nausea and vomiting (53.1%) and dysuria (23.4%). The risk
factors pertaining to urolithiasis in the study subjects were decreased
water consumption (67.2%), previous history of stones (21.9%), family
history of stones (20.3%) and smoking (10.9%).
Table 1 shows the overall and gender wise distribution of median
(IQR) of 24 h urinary oxalate and spot oxalate to creatinine ratio with
distribution of subjects with high oxalate excretion. Six subjects (5 males
and 1 female) had high 24 h urine oxalate excretion, of which 5 had high
spot oxalate to creatinine ratio. Spot oxalate: creatinine ratio was high
among 51 patients (42 males and 9 females). Table 2 shows the com
parison of 24 h urinary oxalate and spot oxalate to creatinine ratio in 7
subjects with calcium oxalate crystals on stone analysis. Only 2 subjects
had hyperoxaluria in contrast to all subjects with high spot oxalate to
creatinine ratio. Taking 24 h urinary oxalate as gold standard the
sensitivity, specificity, positive predictive value and negative predictive
value of spot oxalate to creatinine ratio was 83.3%, 17.8%, 9.8% and
90.9% respectively in diagnosing hyperoxaluria.
Poor concordance was seen between 24 h oxalate excretion and spot
oxalate to creatinine ratio in the subjects studied with a kappa value
0.037. Poor correlation (r = 0.289) was found between 24 h urine ox
alate and oxalate to creatinine ratio by applying Spearmans correlation.
However, it was statistically significant (p value < 0.005), as shown in
Fig. 1.

1. Material & methods
A cross-sectional study was conducted at Section of Chemical Pa
thology, Department of Pathology and Laboratory Medicine, Aga Khan
University, Karachi from 1st February to December 31, 2019. Adult
patients with history of kidney stones presenting at the Clinical Labo
ratory for 24 h urine oxalate estimation were included in the study.
Debilitated or bed ridden patients and patients with renal failure or end
stage renal disease, in whom urinary oxalate is no longer an indicator of
disease status were excluded from the study. Study was approved by
ethical review committee of Aga Khan University Hospital. Patients after
informed consent, were guided to submit a spot urine sample. Clinical
details were recorded on a structured questionnaire by the principal
investigator.
24 h urine samples were collected in a jar having thymol, which is
routinely added to limit bacterial growth and hence guard against citrate
degradation. Spot urine samples were collected in red top container
without any added preservatives. The specimen were transported to the
laboratory within the 12 h of collection of 24 h urinary specimen.
Volume of 24 h urine was measured in liters. After mixing of the
urinary sample to overcome effects of sedimentation, a 6 mL aliquot was
made and HCl was added to avoid the precipitation of oxalate crystals in
every sample. Specimen was stored at − 20C till further analysis.
Urinary oxalate was measured on Micro lab 300 using a kit based on
oxalate oxidase principle by Trinity Biotech plc. Wick low, Ireland
following standard operating procedures. Urinary creatinine was
measured on ADVIA 1800 by Siemens, US using kinetic Jaffe reaction.
Both normal and abnormal quality control materials were run with
every batch of oxalate and creatinine analysis in urine to validate the
results. In addition, external proficiency testing of urinary oxalate was
conducted by College of American Pathologists (CAP).
The cut-offs for 24 h oxalate excretion was 502 ųmol/24 h for males
and 353 ųmol/24 h for females. The cut-offs for spot oxalate: creatinine
ratio was 33 ųmol/mmol for males and 45 ųmol/mmol for females [10].

Table 1
Comparison of overall and elevated median (IQR) of urinary oxalate excretion in
24-h & spot urine samples in both genders (n = 62).
Median
(IQR)

24 h urine oxalate
in umol/24 h
Spot urine oxalate
to creatinine
ratio in ųmol/
mmol

217
(138.2)
63.3
(45.6)

No of Patients with High Oxalate Value in Each
Group
Male (n = 49)

Female (n = 13)

N (%)

Median
(IQR)

N (%)

Median
(IQR)

5
(10.2%)
42
(85.7%)

592.8
(189.2)
77.5
(48.5)

1
(7.6%)
9
(69.2%)

370.5*
69.3
(39.9)

For 24 h urine oxalate excretion cutoff used of 502 μmol/24 h was used for
labelling Hyperoxaluria in males while in females a cutoff 353 μmol/24 h was
applied. For spot urine oxalate to creatinine ratio a cutoff of 33 ųmol/mmol was
used for identifying Hyperoxaluria in males while in females a cutoff 45 ųmol/
mmol was applied [9].
*IQR not calculated.

1.1. Statistical analysis
Data was entered and analyzed in to SPSS 22 version. To check the
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related measurements because the measurement with a larger range of
true quantity in the sample will have a higher correlation, in which
solute/creatinine ratio of a single urinary parameter can vary widely in
range, thus ensuring a significant correlation. The reason for the
disagreement is believed to be mainly due to the time-to-time variations
in the urinary solute concentrations (urinary volume) that vary ac
cording to the body hydration status, diurnal circadian rhythm and di
etary patterns affecting oxalate excretion [12].
Primary hyperoxaluria or oxalosis is associated with recurrent renal
stone formation that usually begins in childhood [11]. Therefore in
patients with recurrent renal calculi or unexplained renal failure pri
mary hyperoxaluria must be considered as an important, though rare
diagnosis. Prompt diagnosis and appropriate management are crucial.
For screening and accurate identification of primary hereditary hyper
oxaluria or secondary hyperoxaluria it is essential to quantitate urinary
oxalate [13]. As daily urine collection for determining oxalate excretion
is cumbersome we studied the relation of daily oxalate excretion with
oxalate: creatinine ratio in randomly collected urine sample. In the stone
formers studied, only six patients out of the total sixty two patients
showed elevated urinary oxalate excretion however the spot oxalate:
creatinine ratio was high in 51 patients. Poor concordance was seen
between 24 h oxalate excretion and spot oxalate to creatinine ratio in the
subjects studied with a kappa value 0.037. Considering twenty four
urinary oxalate excretion as the gold standard the study shows hyper
oxaluria in 9.6% (n = 6) of the patients studied.

Table 2
Comparison of 24 h urinary oxalate and spot urine oxalate to creatinine ratio in
patients tested by stone analysis (n = 7).
S⋅NO*

Age
(Years)

Gender

24 h urine
oxalate (umol/
24 h)

Spot urine Ox/
Cr (ųmol/
mmol)

Family
History

1
2
3
4
5
6
7

40
29
58
26
23
19
22

Male
Male
Male
Male
Male
Male
Male

539.2
513
228
305.5
216.6
148.2
114

94.7
109
64.5
139.1
83.3
89
83.6

Present
Absent
Absent
Absent
Absent
Present
Absent

*All subjects had calcium oxalate crystals on stone analysis.

3.1. Limitations
The limitations in our study included single centre study and small
sample size. Also the dietary habits, environmental conditions, body
composition were not assessed.
4. Conclusion
In conclusion, the random spot urine test cannot replace the 24 h
urinary oxalate estimation in patients with urolithiasis. Further studies
should be conducted taking diet, water intake, drugs and comorbidity
into consideration and understand the influence of diet on 24 h urine
oxalate and spot urine oxalate to creatinine ratio.

Fig. 1. Relation of Spot oxalate to creatinine ratio to 24 h oxalate excre
tionCorrelation between the two tests was assessed by Spearman’s correlation
coefficient (r = 0.289).
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To the best of our knowledge, this is the first study about relationship
between 24 h urine oxalate and spot oxalate to creatinine ratio in Pak
istani population. Several studies have assessed the prospect of using
spot urine or timed, urine samples for metabolic evaluation in patients
with urolithiasis. Studies have reported good correlations between the
24 h urine calcium and phosphate excretions and their corresponding
spot urine calcium/creatinine and phosphate/creatinine ratios but there
is not much literature on oxalate comparison in 24 h and spot sample in
stone formers [8,10]. Some investigators have argued on the association
between the 24 h urinary excretion and their corresponding spot urine
creatinine ratio as a good indicator for using the spot urine sample in
replacement to the 24 h urine sample. Yet Hoi Hong investigated the
correlations and agreements between the solute/creatinine ratios from
the 24-h and early morning spot urine samples for metabolic evaluation
in stone-formers. The investigators reported poor correlation (r = 0.352)
of 24 h oxalate excretion and spot urinary oxalate: creatinine ratio. They
concluded that morning spot urine is not appropriate and cannot replace
the 24-h urine collection in the evaluation of urinary metabolic abnor
malities in stone-formers [4]. However, the correlation coefficient may
not be the appropriate statistical test in assessing whether measurements
from the two methods agree with each other as in our study [11]. A high
correlation does not represent a good agreement between the two
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